New Test in Fragile X FMR1 Expansion
Learn more about Xpansion Interpreter®
Introducing Asuragen Tech Talks
Provocative, case-study driven presentations on cutting edge topics. Click here to access Asuragen Tech Talks.
Three new biomarker companies selected to work with Abcodia and the Early Cancer Consortium| read more »
Asuragen to present at upcoming Association for Molecular Pathology Annual Meeting in National Harbor, MD| read more »
Asuragen Launches the Quantidex™ DNA Assay to Improve the Accuracy of Next-Generation Sequencing| read more »
Asuragen’s Xpansion Interpreter® Test Study of 1,040 Transmissions of Fragile X Alleles Reveals Personalized Risks for | read more »